IDEAS home Printed from https://ideas.repec.org/p/pra/mprapa/113416.html
   My bibliography  Save this paper

Regulating the Pharmaceutical Industry: An Analysis of the Drug Regulatory Authority of Pakistan (DRAP)

Author

Listed:
  • Mehmood, Shahid

Abstract

Healthy lives and the longevity of humans over time have critically been dependent upon the availability of quality drugs. Therefore, regulating the pharmaceutical industry for ensuring quality drugs and quality services (like drug dispensing) have traditionally been a priority for governments all around the globe. Pakistan is no exception, and at present has DRAP as its regulator of the pharmaceutical industry. Founded in 2012, few studies have analysed the performance of DRAP to date, and even those are limited in content, coverage and data. In sum aggregate, DRAPs performance is better than its predecessor, but there are still significant gaps to be filled and significant challenges to be addressed.

Suggested Citation

  • Mehmood, Shahid, 2022. "Regulating the Pharmaceutical Industry: An Analysis of the Drug Regulatory Authority of Pakistan (DRAP)," MPRA Paper 113416, University Library of Munich, Germany.
    • Handle: RePEc:pra:mprapa:113416
    as

    Download full text from publisher

    File URL: https://mpra.ub.uni-muenchen.de/113416/1/MPRA_paper_113416.pdf
    File Function: original version
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Shehla Zaidi & Maryam Bigdeli & Noureen Aleem & Arash Rashidian, 2013. "Access to Essential Medicines in Pakistan: Policy and Health Systems Research Concerns," PLOS ONE, Public Library of Science, vol. 8(5), pages 1-10, May.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Amna Saeed & Hamid Saeed & Zikria Saleem & Yu Fang & Zaheer-Ud-Din Babar, 2019. "Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: A cross-sectional survey using WHO/HAI methodology," PLOS ONE, Public Library of Science, vol. 14(4), pages 1-16, April.
    2. Ayeesha Kamran Kamal & Wardah Khalid & Abdul Muqeet & Anum Jamil & Kashfa Farhat & Sehar Rahim Ali Gillani & Maryam Zulfiqar & Mehreen Saif & Aliya Amin Muhammad & Fabiha Zaidi & Mohammad Mustafa & Am, 2018. "Making prescriptions “talk” to stroke and heart attack survivors to improve adherence: Results of a randomized clinical trial (The Talking Rx Study)," PLOS ONE, Public Library of Science, vol. 13(12), pages 1-24, December.
    3. Muhammad Atif & Iram Malik, 2020. "Why is Pakistan vulnerable to COVID‐19 associated morbidity and mortality? A scoping review," International Journal of Health Planning and Management, Wiley Blackwell, vol. 35(5), pages 1041-1054, September.
    4. De Guzman, Eleanora & Fausto, Maria Adoracion, 2014. "The Impact of the Cheaper Medicines Act on Households in Metro Manila: A Qualitative Study," Discussion Papers DP 2014-20, Philippine Institute for Development Studies.

    More about this item

    Keywords

    Pakistan Pharmaceutical Industry; Pharmaceutical Regulation; Regulation; DRAP; Pakistan; Medicines;
    All these keywords.

    JEL classification:

    • I18 - Health, Education, and Welfare - - Health - - - Government Policy; Regulation; Public Health
    • I3 - Health, Education, and Welfare - - Welfare, Well-Being, and Poverty
    • I38 - Health, Education, and Welfare - - Welfare, Well-Being, and Poverty - - - Government Programs; Provision and Effects of Welfare Programs

    NEP fields

    This paper has been announced in the following NEP Reports:

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:pra:mprapa:113416. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Joachim Winter (email available below). General contact details of provider: https://edirc.repec.org/data/vfmunde.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.